Buy These 2 Quantum Stocks Now For Up to 5,233% Gains by 2035.

IonQ (IONQ) and D-Wave Quantum (QBTS) pursue different quantum-computing technologies—trapped ions and quantum annealing respectively—with both viewed as having very large but highly uncertain upside. McKinsey projects a $28–$72 billion annual market by 2035 (midpoint $50B); assuming a hypothetical 90% winner share implies ~$45B in revenue, which the author equates to a potential rise to a ~ $400B market cap (implying roughly 5,233% upside for D-Wave or 2,885% for IonQ from current market caps of ~$7.5B and ~$13.4B). The note stresses the high failure risk, stiff competition, and recommends small initial positions while disclosing the author and Motley Fool positions in related tech names.

Analysis

Market structure: Hyperscalers (AWS/MSFT/GOOG) and classical-accelerator incumbents (NVDA/AMD/INTC) are the likely early winners because they can bundle quantum access and shore up demand; small-cap pure-plays IONQ (13.4B mkt cap) and QBTS (7.5B) are binary bets on technology and go-to-market execution. Pricing power will be winner-takes-most if a clear platform emerges, but today demand is latent and supply (qubits, cryogenics, control electronics, helium) is constrained — expect periodic scarcity-driven price spikes for specialty inputs. A public breakthrough would spike small-cap tech equities, lift implied vol, tighten credit spreads for QC vendors, and modestly strengthen the USD via defense/government contract flow; helium and cryogenic supply chains merit commodity watchlists.

Risk assessment: Tail risks include rapid obsolescence (a different qubit tech wins), national-security export controls cutting China/EM revenue, and equity dilution >20–30% if R&D burn continues; any of these can wipe out >80% of current market caps. Immediate (days) risk is IV spikes around announcements; short-term (3–6 months) hinge on partnerships and revenue cadence; long-term (2–10 years) depends on demonstrated quantum advantage and fault-tolerant scaling. Hidden dependencies: hyperscaler partnerships, access to cryogenic/laser supply, and classical algorithmic advances that prolong classical competitiveness. Catalysts to watch: certified hyperscaler contract >$50–100M, published demonstrable advantage on a commercial workload within 12–24 months, or large strategic M&A (NVDA/AMD/INTC buyer).

Trade implications: Use small, asymmetric positions: treat IONQ/QBTS as option-like exposure (1%–2% portfolio each max). Preferred structure: staggered cash buys plus LEAPS or call spreads (18–30 months) to capture convex upside while limiting cash risk; size short exposures only as tactical pair trades vs overstated movers. Pair idea: long IONQ / short QBTS (2:1) if market begins to price annealing as equivalent to universal QC without revenue proof. Rotate modestly into NVDA and cloud infra (AMZN/MSFT) by +1–3% as defensive exposure to quantum commercialization benefits. Entry should be staggered over 30–90 days; exit on revenue misses (QoQ <10% or two consecutive misses) or dilution breaches (>15% raise).

Contrarian angles: The market underestimates timeline and dilution risk — current valuations price multi‑year success that is binary; upside concentration suggests tiny stakes with high convexity, not large core positions. Historical parallel: early GPU adoption (NVDA) rewarded winner-take-most, but many early chip names failed — don’t assume two winners; acquisition by a deep-pocket acquirer could either validate or annihilate current equity holders. Mispricing opportunities exist in vol: sell short-dated calls after breakthrough rallies and buy long-dated calls before known catalysts to exploit term-structure mispricings. Unintended consequence: a hyperscaler lock-in or standards consolidation could render both pure-plays obsolete rapidly.

Key Decisions for Investors

• Establish a 1.0% portfolio long in IONQ within 30 days, dollar-cost average over 3 trades; allocate 40% of that exposure to 18–30 month call spreads (LEAPS) to limit downside. If IONQ signs a hyperscaler or government contract >$50M or demonstrates a quantifiable advantage on a commercial workload within 12 months, increase to 3.0%.
• Establish a 0.5% portfolio long in QBTS as optionality, funded 50% by buying 24-month OTM calls (target delta 25–35%) rather than full equity. Reduce to zero if QoQ revenue growth <5% for two consecutive quarters or if a capital raise dilutes equity by >15% within 12 months.
• Implement a tactical pair trade: long IONQ 1.5% vs short QBTS 0.75% (2:1) if QBTS rallies >50% in 60 days without corresponding revenue/guidance improvement; target profit 50–100% or apply a 30% stop-loss on the pair. Close within 6 months absent fundamental confirmation.
• Reallocate +2% from cyclical small-cap tech into NVDA and cloud infra (split between NVDA and AMZN/MSFT) within 30 days to hedge commercialization of early quantum workloads; reassess allocation at 6 months or after any major public quantum breakthrough.
• Monitor specific triggers over the next 90 days: increase/decrease positions within 5 trading days if either company announces a government/hyperscaler contract >$100M, or an equity raise >$200M — act to reduce exposure by at least 50% on dilution >20% or revenue guidance misses >10%.